About this trial
The primary aim of this study is to test and assess the implementation and effectiveness of continuous wireless vital signs monitoring with real-time alerts on:
The frequency of patients monitored with adequate data quality as adequate clinical user satisfaction in the initial versus the last part of the trial (primary outcome).
Eligibility criteria
Qualifiers
Adult participants (≥18 years)
Patients assessed by the clinical staff as having an acute condition with risk for clinical deterioration and being either at home (with no apparent need for hospitalization), and/or in hospital OR
Patients at either at home before, in-hospital and/or after hospitalization for elective major surgery, defined as surgery lasting more than one hour under general- or regional anaesthesia
Disqualifiers
The participant expected not to cooperate with study procedures.
Allergy to plaster or silicone.
Having pacemaker or Implantable Cardioverter Defibrillator (ICD) device.
Inability to give informed consent.
Trial design
Treatments tested in this trial
- Vital signs measurements with new app
Treatment groups
Sponsors and collaborators
University Hospital Bispebjerg and Frederiksberg
Lead sponsor
Rigshospitalet, Denmark
Collaborator